Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 2
1949 1
1950 2
1951 2
1953 2
1954 4
1955 5
1956 3
1957 2
1958 1
1959 4
1960 1
1961 1
1962 3
1963 28
1964 41
1965 27
1966 29
1967 31
1968 49
1969 48
1970 48
1971 56
1972 50
1973 82
1974 73
1975 90
1976 75
1977 63
1978 61
1979 60
1980 63
1981 50
1982 58
1983 78
1984 78
1985 69
1986 79
1987 55
1988 50
1989 64
1990 69
1991 68
1992 71
1993 65
1994 78
1995 85
1996 94
1997 102
1998 100
1999 109
2000 111
2001 137
2002 150
2003 187
2004 148
2005 173
2006 245
2007 200
2008 159
2009 132
2010 134
2011 121
2012 137
2013 136
2014 143
2015 124
2016 149
2017 146
2018 162
2019 165
2020 161
2021 171
2022 168
2023 146
2024 155
2025 74

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,935 results

Results by year

Filters applied: . Clear all
Page 1
Urea-containing topical formulations.
Annunziata MC, Cacciapuoti S, Cosentino C, Fabbrocini G. Annunziata MC, et al. Int J Clin Pract. 2020 Dec;74 Suppl 187:e13660. doi: 10.1111/ijcp.13660. Int J Clin Pract. 2020. PMID: 33249709
Urea is a well-known moisturiser and keratolytic topical agent. As it is widely used in dermatology, several formulations at different concentrations have been marketed: lotions, creams, foams, ointments, gels and lacquers. ...
Urea is a well-known moisturiser and keratolytic topical agent. As it is widely used in dermatology, several formulations at differen …
Tirbanibulin: Topical Treatment for Actinic Keratosis.
Dlott AH, Di Pasqua AJ, Spencer SA. Dlott AH, et al. Clin Drug Investig. 2021 Sep;41(9):751-755. doi: 10.1007/s40261-021-01068-9. Epub 2021 Aug 5. Clin Drug Investig. 2021. PMID: 34351607 Review.
This article discusses the clinical trials that led to the approval of tirbanibulin and comparison with other approved topical ointments indicated for the treatment of AK. In the clinical trials, all participants experienced a decrease in lesion size or saw complete …
This article discusses the clinical trials that led to the approval of tirbanibulin and comparison with other approved topical oin …
Topical drug classification.
Buhse L, Kolinski R, Westenberger B, Wokovich A, Spencer J, Chen CW, Turujman S, Gautam-Basak M, Kang GJ, Kibbe A, Heintzelman B, Wolfgang E. Buhse L, et al. Int J Pharm. 2005 May 13;295(1-2):101-12. doi: 10.1016/j.ijpharm.2005.01.032. Int J Pharm. 2005. PMID: 15847995
The purpose of this study is to obtain a scientifically based, systematic classification of dosage forms for topical drugs. A variety of prescription and over-the-counter topical products currently marketed as lotions, gels, creams, and ointments are evaluate …
The purpose of this study is to obtain a scientifically based, systematic classification of dosage forms for topical drugs. A variety …
The wound/burn guidelines - 6: Guidelines for the management of burns.
Yoshino Y, Ohtsuka M, Kawaguchi M, Sakai K, Hashimoto A, Hayashi M, Madokoro N, Asano Y, Abe M, Ishii T, Isei T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kukino R, Kono T, Kodera M, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hasegawa M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Yamasaki O, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. Yoshino Y, et al. J Dermatol. 2016 Sep;43(9):989-1010. doi: 10.1111/1346-8138.13288. Epub 2016 Mar 12. J Dermatol. 2016. PMID: 26971391
Burns are a common type of skin injury encountered at all levels of medical facilities from private clinics to core hospitals. Minor burns heal by topical treatment alone, but moderate to severe burns require systemic management, and skin grafting is often necessary also f …
Burns are a common type of skin injury encountered at all levels of medical facilities from private clinics to core hospitals. Minor burns h …
Advanced topical formulations (ATF).
Hadgraft J, Lane ME. Hadgraft J, et al. Int J Pharm. 2016 Nov 30;514(1):52-57. doi: 10.1016/j.ijpharm.2016.05.065. Epub 2016 May 31. Int J Pharm. 2016. PMID: 27260130 Review.
Despite the use of creams and ointments over the millennia, the bioavailability of actives from topical preparations remains quite low, often not exceeding 1-2% of the applied dose. In this review we examine the reasons underlying the poor performance of topical …
Despite the use of creams and ointments over the millennia, the bioavailability of actives from topical preparations remains q …
Topical tacrolimus in high-risk corneal transplants.
Bernardes L, Gil J, Costa E, Tavares C, Rosa A, Quadrado MJ, Murta J. Bernardes L, et al. Eur J Ophthalmol. 2024 Jan;34(1):140-145. doi: 10.1177/11206721231172236. Epub 2023 May 1. Eur J Ophthalmol. 2024. PMID: 37128645
METHODS: We conducted an observational, retrospective study using clinical data of high-risk patients subjected to penetrating keratoplasty, who were treated with topical tacrolimus ointment 0.2 mg/g twice a day plus topical dexamethasone 0.1 mg/ml 6 id and compared …
METHODS: We conducted an observational, retrospective study using clinical data of high-risk patients subjected to penetrating keratoplasty, …
Treating pressure sores.
[No authors listed] [No authors listed] Br Med J. 1978 May 13;1(6122):1232. Br Med J. 1978. PMID: 647208 Free PMC article. No abstract available.
Dressings and topical agents for arterial leg ulcers.
Broderick C, Pagnamenta F, Forster R. Broderick C, et al. Cochrane Database Syst Rev. 2020 Jan 20;1(1):CD001836. doi: 10.1002/14651858.CD001836.pub4. Cochrane Database Syst Rev. 2020. PMID: 31978262 Free PMC article.
This is the third update of a review first published in 2003. OBJECTIVES: To determine whether topical agents and wound dressings affect healing in arterial ulcers. To compare healing rates and patient-centred outcomes between wound dressings and topical agents. ... …
This is the third update of a review first published in 2003. OBJECTIVES: To determine whether topical agents and wound dressings aff …
Topical treatment in vitiligo and the potential uses of new drug delivery systems.
Garg BJ, Saraswat A, Bhatia A, Katare OP. Garg BJ, et al. Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):231-8. doi: 10.4103/0378-6323.62961. Indian J Dermatol Venereol Leprol. 2010. PMID: 20445292 Free article. Review.
Vitiligo is a psychologically devastating condition. Topical therapy is employed as first-line treatment in localized vitiligo. Currently, several topical agents are available in many forms viz. methoxsalen (solution and cream), trioxsalen (solution), corticosteroid …
Vitiligo is a psychologically devastating condition. Topical therapy is employed as first-line treatment in localized vitiligo. Curre …
Topical sirolimus: Difference between compounded preparations and commercial oral solution.
Brichta L, Carver JG, Carver DeKlotz CM. Brichta L, et al. Pediatr Dermatol. 2021 Jul;38(4):967-969. doi: 10.1111/pde.14637. Epub 2021 Jun 1. Pediatr Dermatol. 2021. PMID: 34060128
Topical sirolimus has become a crucial treatment option for many dermatologic disorders. Because an FDA-approved topical formulation is not commercially available, sirolimus creams, ointments, and gels are professionally prepared by compounding pharmacies. .. …
Topical sirolimus has become a crucial treatment option for many dermatologic disorders. Because an FDA-approved topical formu …
5,935 results